Bill Search

HB 2107
  • Introduced
    Feb 06, 2023
  • Passed House
    Mar 09, 2023
  • Passed Senate
  • Signed into Law
HB 2107
Oklahoma House Bill
Did you know we offer free bill tracking in Congress and 50 states, and a great mobile app? Sign up here
Controlled dangerous substances; authorizing certain scientific research and clinical trials related to psilocybin and psilocyn; requiring registration; providing certain immunities; effective date.
Last Action See all actions
Senate • Mar 29, 2023: Second Reading referred to Health and Human Services Committee then to Appropriations Committee
Latest Bill Text See all bill texts
Engrossed

Official Summary/Bill Text

Comments on HB 2107

Tweets

Whip Lists

Sponsors
Votes
Feb 15, 2023, House
DO PASS AS AMENDED BY CS
YES: 6
NO: 1
OTHER: 0
YES: 6

NO: 1

OTHER: 0
Sources
Mar 09, 2023, House
THIRD READING
YES: 66
NO: 32
OTHER: 3
YES: 66

NO: 32

EXCUSED: 3

Sources
Actions
  • Mar 29, 2023 | Senate
    • Second Reading referred to Health and Human Services Committee then to Appropriations Committee
  • Mar 14, 2023 | Senate
    • Coauthored by Representative Rosecrants
    • Coauthored by Representative Munson
  • Mar 13, 2023 | Senate
    • First Reading
  • Mar 13, 2023 | House
    • Engrossed, signed, to Senate
  • Mar 09, 2023 | House
    • General Order
    • Coauthored by Representative(s) Talley, Hefner, Deck
    • Authored by Senator Brooks (principal Senate author)
    • Amended
    • Title stricken
    • Third Reading, Measure passed: Ayes: 66 Nays: 32
    • Referred for engrossment
  • Feb 15, 2023 | House
    • CR; Do Pass, amended by committee substitute Alcohol, Tobacco and Controlled Substances Committee
  • Feb 07, 2023 | House
    • Second Reading referred to Alcohol, Tobacco and Controlled Substances
  • Feb 06, 2023 | House
    • First Reading
    • Authored by Representative Pae
Bill Texts
Documents
Sources